Form 4: Verizon Executive Kyle Malady Sells 5,000 Shares of Common Stock
SEC Form 4
EVP and Group CEO of Verizon Business, Kyle Malady, sold 5,000 shares of Verizon Communications Inc. common stock on April 23, 2025, at a price of $42.485 per share.
Summary
- On April 23, 2025, Kyle Malady, EVP and Group CEO-VZ Business at Verizon Communications Inc., sold 5,000 shares of common stock.
- The sale price was $42.485 per share.
- Following the transaction, Malady directly owns 36,508 shares of Verizon common stock.
- Malady also indirectly owns 18,412 shares through a 401(k) plan.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports a transaction. It doesn't indicate positive or negative outlook for the company.
Industry Context
Form 4 filings are standard disclosures required by the SEC when corporate insiders, like Kyle Malady, trade their company's stock. These filings are closely watched by investors for insights into management's perspective on the company's valuation and future prospects.
Stakeholder Impact
- The sale of shares by a high-ranking executive could be perceived negatively by some shareholders, potentially leading to speculation about the executive's confidence in the company's future performance.
Key Dates
| Date | Description |
|---|---|
| 04/23/2025 | Date of transaction: Sale of 5,000 shares of common stock. |
| 04/24/2025 | Date of signature on the Form 4 filing. |
Keywords
Verizon, VZ, Kyle Malady, Stock Sale, Form 4, Executive Compensation, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.